{"id":"898c5202-5ecc-4c36-93da-07914459053e","kind":"news","code":"898c5202-5ecc-4c36-93da-07914459053e","name":"Converge Bio raises USD 25 million in Series A financing","nameBasis":"translated-title","summary":"On 2026-01-13, according to Xiniu Data, Converge Bio completed Series A financing, raising USD 25 million. Investors were Bessemer Venture Partners, Vintage Investment Partners.","description":"","country":null,"category":null,"originalName":"Converge Bio完成A轮融资，金额2500万美元","eventDate":"2026-01-13T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T06:18:29.526Z","englishUpdatedAt":"2026-10-20T18:21:37.602Z","reviewedAt":"2026-10-20T18:21:37.602Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"e5a22c553285b55b5a582c60994ccced02395ee35f596b184430ef2f6bb4d498","companyId":"1c8db465-a37b-44b9-8f21-ffc581574281","foundedYear":null,"logoUrl":null,"originalText":"2026年1月13日，据烯牛数据报道，Converge Bio完成A轮融资，金额2500万美元。投资方为Bessemer Venture Partners、Vintage Investment Partners。","sources":[],"related":[{"id":"77beeeb4-8c29-41f9-abc0-9acea2904990","kind":"institutions","code":"UB-I134","name":"Bessemer Venture Partners","nameBasis":"original-brand","summary":"A longstanding global venture capital firm focused on early-stage technology and healthcare investments.","description":"A longstanding global venture capital firm focused on early-stage technology and healthcare investments.","country":"United States","category":null,"originalName":"Bessemer Venture Partners","eventDate":null,"website":"https://bvp.com/","sourceUpdatedAt":"2026-10-18T22:00:13.030Z","englishUpdatedAt":"2026-10-20T18:26:56.770Z","reviewedAt":"2026-10-20T18:26:56.770Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"5d97f6e037182710714dab9730302ca949f8197901b9e3b5cdb9fc356058fba2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bessemer-venture-partners"},{"id":"1c8db465-a37b-44b9-8f21-ffc581574281","kind":"companies","code":"UB-C7434","name":"Converge Bio","nameBasis":"source-english","summary":"Life sciences AI model platform for biotechnology and drug design","description":"","country":null,"category":null,"originalName":"Converge Bio","eventDate":null,"website":"https://converge-bio.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:22:58.261Z","reviewedAt":"2026-10-20T18:22:58.261Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"b25c23c3315a2bb8f189743a6ce8215c6d637aba1e60d2d8452c44ca6c1e9de7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/converge-bio"},{"id":"dea45e78-fb97-402c-b38c-c99d10ade953","kind":"institutions","code":"UB-I643","name":"Vintage Investment Partners","nameBasis":"original-brand","summary":"Fund of funds and secondary investment firm.","description":"Fund of funds and secondary investment firm.","country":"Israel","category":null,"originalName":"Vintage Investment Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:20.104Z","englishUpdatedAt":"2026-10-20T18:27:03.879Z","reviewedAt":"2026-10-20T18:27:03.879Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"acb079750d39d28f886085dd9e6ae0c99ffc01dbe0cbe91fefa7388ec680f50e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/vintage-investment-partners"}],"path":"/news/898c5202-5ecc-4c36-93da-07914459053e","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Converge Bio","path":"/companies/converge-bio"}},"canonical":"https://uniquebase.ai/news/898c5202-5ecc-4c36-93da-07914459053e"}